secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2023-05-12T23:59:59+00:00
Accession:  0001493152-23-016739
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.02, 5.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve conversion of preferred shares; outstanding common to increase ~44% to 2.3M
--------------------------------------------------------------------------------

- Special meeting on May 8, 2023: all four proposals passed, including conversion of Series C & D preferred into common.
- Convertible notes with £1.36M outstanding balance to convert into 1,149,273 Series C shares, effective May 9.
- Upon full conversion of Series C (3.5M shares) and Series D (176k shares), common outstanding will be ~2.29M (up from ~1.58M).
- 2019 Long Term Incentive Plan amended to increase authorized shares by 50,000 to 125,000 (Proposal 3 approved).
- All conversions are in process and deemed effective as of May 10, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315223016739/0001493152-23-016739-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315223016739/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-016739

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer